Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk

Original language	American English
State	Published - 2014
Event	American Society of Clinical Psychopharmacology - Hollywood, United States Duration: 8 Jun 2014 → 13 Jun 2014

Conference

Conference	American Society of Clinical Psychopharmacology
Country/Territory	United States
City	Hollywood
Period	8/06/14 → 13/06/14

Activities

• 1 Organizing a conference, workshop, ...

Activities per year

• American Society of Clinical Psychopharmacology

  Rabinowitz, J. (Participation - Conference participant)

  8 Jun 2014 → 13 Jun 2014

  Activity: Participating in or organizing an event › Organizing a conference, workshop, ...

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Rabinowitz, J. (2014). Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk. Paper presented at American Society of Clinical Psychopharmacology, Hollywood, United States.

Rabinowitz, J. / Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk. Paper presented at American Society of Clinical Psychopharmacology, Hollywood, United States.

@conference{e8d5974428484a588c09f53a6b9824d7,

title = "Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk",

author = "J. Rabinowitz",

year = "2014",

language = "American English",

note = "American Society of Clinical Psychopharmacology ; Conference date: 08-06-2014 Through 13-06-2014",

}

Rabinowitz, J 2014, 'Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk', Paper presented at American Society of Clinical Psychopharmacology, Hollywood, United States, 8/06/14 - 13/06/14.

Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk. / Rabinowitz, J.
2014. Paper presented at American Society of Clinical Psychopharmacology, Hollywood, United States.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk

AU - Rabinowitz, J.

PY - 2014

Y1 - 2014

M3 - Paper

T2 - American Society of Clinical Psychopharmacology

Y2 - 8 June 2014 through 13 June 2014

ER -

Rabinowitz J. Evidence and risks of duplicate subjects in clinical trials and how you can minimize the risk. 2014. Paper presented at American Society of Clinical Psychopharmacology, Hollywood, United States.